Managing type 2 diabetes and managing weight are not separate problems. For most people living with the condition, they are the same problem approached from two different directions. The medication that controls blood sugar often does not help with weight. The diets that help with weight do not resolve the metabolic picture. You work hard at one and the other barely moves. What makes Mounjaro different for patients with type 2 diabetes is that it addresses both at once, and the clinical evidence behind that is considerable.
For patients in Swansea with type 2 diabetes who are overweight or living with obesity, Mounjaro is one of the most effective private weight management options currently available for this patient group. Medihub Pharmacy offers private Mounjaro prescribing at two Swansea branches, Killay and Pontarddulais, with face-to-face consultations, same-day prescribing, and no GP referral required.
This guide covers how Mounjaro works for patients with type 2 diabetes, what the clinical evidence shows, who is eligible, and what to expect from treatment at Medihub.
Mounjaro for Type 2 Diabetes in Swansea
Patients with type 2 diabetes are eligible for Mounjaro at Medihub Pharmacy as part of a private weight management programme. Two branches in Swansea, Killay and Pontarddulais. GPhC-registered Independent Prescribers. Same-day prescribing. No GP referral required. Monthly face-to-face consultation, blood pressure check, and weight check included in every price.
How Mounjaro Works and Why It Matters for Type 2 Diabetes
Mounjaro (tirzepatide) was originally developed as a diabetes medication before its weight management potential became clear from clinical trials. It works by mimicking two gut hormones simultaneously: GLP-1 and GIP. Both are naturally produced after eating and play a role in regulating insulin secretion, blood sugar, and appetite. By activating both pathways at once, tirzepatide achieves something single-pathway medications cannot.
For patients with type 2 diabetes, this dual mechanism has a compound effect. GLP-1 activation stimulates insulin secretion when blood glucose is elevated and slows gastric emptying. GIP activation improves insulin sensitivity and works on fat tissue as well as the pancreas. Together they address two of the core drivers of type 2 diabetes: excess weight and impaired insulin response. Reducing one tends to improve the other. Mounjaro addresses both simultaneously, which is why its results in diabetic populations differ from those seen with older GLP-1 medications.
It is important to be clear about how Medihub prescribes Mounjaro. At both Swansea branches, Mounjaro is prescribed as a weight management treatment for eligible patients. Type 2 diabetes qualifies you as eligible under the MHRA-approved criteria. The weight loss that follows has a clinically meaningful secondary effect on blood sugar and HbA1c. Your Medihub prescriber is prescribing for weight management, not managing your diabetes directly. Patients should continue working with their GP or diabetes care team throughout treatment, particularly regarding any existing diabetes medications.
SURMOUNT-2 Clinical Trial: Type 2 Diabetes Patients
15.7%
average body weight loss over 72 weeks
Participants had type 2 diabetes and received tirzepatide 15mg weekly alongside a reduced-calorie diet and increased physical activity. Individual results vary. Source: Jastreboff et al., NEJM, 2022.
SURMOUNT-2 is the clinical trial most directly relevant to patients with type 2 diabetes. Conducted specifically in this patient group, it found an average weight loss of 15.7% at the 15mg dose over 72 weeks. That compares favourably with earlier clinical data for semaglutide in the same population, where the STEP-2 trial found average weight loss of 9.6%. The clinical gap between the two medications is wider in diabetic patients than in those without the condition.
What Happens to Blood Sugar
The weight loss achieved with Mounjaro typically produces a measurable improvement in blood sugar control. As body weight reduces and insulin sensitivity improves, HbA1c levels tend to fall. In the SURPASS-2 clinical trial, which compared tirzepatide directly against semaglutide in type 2 diabetes patients, tirzepatide reduced HbA1c by up to 2.30 percentage points, compared to 1.86 percentage points with semaglutide, and it outperformed semaglutide at every dose tested.
For patients who are currently on diabetes medication, this is an important practical consideration. As blood sugar improves with weight loss, existing medication doses may need to be reviewed by your diabetes care team. Patients taking insulin in particular may find that doses need adjusting as blood glucose levels respond to treatment. This is a clinical decision that should be made with your GP or diabetes specialist, and your Medihub prescriber will flag this clearly at your first consultation.
Important
Patients with type 2 diabetes who are prescribed Mounjaro for weight management should continue working with their GP or diabetes care team throughout treatment. If you are on insulin or sulphonylurea medication, your doses may need reviewing as your blood sugar improves. Do not adjust existing diabetes medication without clinical guidance. Medihub prescribes Mounjaro for weight management. Your diabetes medication management remains with your existing care team.
“Had an appointment with the prescribing chemist Osama, who was incredibly helpful and kind. Gave me all the information I needed in a way I could understand.”
Sophie H. — Google Review
Mounjaro for type 2 diabetes in Swansea
Face-to-face consultation. Same-day prescribing. No GP referral required.
Who Is Eligible for Mounjaro with Type 2 Diabetes?
Eligibility is confirmed at your first consultation by your Medihub prescriber. Type 2 diabetes is specifically listed as a qualifying weight-related condition in the MHRA-approved criteria for Mounjaro. The general guide for private prescribing is:
Standard Eligibility
- BMI of 30 or above
- BMI of 27 or above with at least one weight-related condition. Type 2 diabetes qualifies directly.
Adjusted Thresholds
- Lower thresholds apply for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds
- Typically reduced by 2.5 kg/m² per NICE guidance
Mounjaro is contraindicated in pregnancy and breastfeeding, and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Patients with a history of diabetic retinopathy should be aware that rapid improvement in blood glucose control can be associated with a temporary worsening of retinopathy. This should be discussed with your diabetes care team before starting treatment. The MHRA also advises that Mounjaro may reduce the effectiveness of the oral contraceptive pill and may affect the absorption of oral HRT. Your Medihub prescriber will cover all contraindications fully at your first appointment.
What Treatment at Medihub Looks Like for Diabetic Patients
For patients with type 2 diabetes, the first appointment naturally covers more clinical ground. Your prescriber will review your current diabetes medications, your most recent blood sugar management, any relevant complications, and your full health picture before making a prescribing decision. This is a 30-minute face-to-face consultation, not a form reviewed remotely.
At Killay, consultations are led by Osama Al-Saied, a GPhC-registered Independent Prescriber (GPhC number 2222112, publicly verifiable at pharmacyregulation.org). At Pontarddulais, patients are seen by Mr Carwyn Jones, who holds the same qualification. Independent Prescriber status allows both prescribers to independently assess, diagnose, and prescribe without requiring GP involvement at any stage.
Your first appointment covers
- ✓ Full medical history including current diabetes medications
- ✓ Current weight, BMI, and blood pressure
- ✓ Eligibility assessment for Mounjaro
- ✓ Review of contraindications including retinopathy history
- ✓ Guidance on diabetes medication interaction and the importance of GP liaison
- ✓ Same-day prescription if you are suitable for treatment
Every month after that, you return for a check-in: weight recorded, blood pressure taken, dose reviewed. These appointments are included in your monthly price. The Medihub Pharmacy GPhC registration is publicly verifiable: registration number 9012258.
Medihub Advantage
Every patient is seen face-to-face by a named GPhC-registered Independent Prescriber at every appointment. For patients with type 2 diabetes, that means your prescriber knows your case, reviews your progress in person every month, and can discuss any concerns about your diabetes medication alongside your weight management. Two branches in Swansea. No GP referral required.
Mounjaro Pricing at Medihub Swansea
All six Mounjaro doses are available at both branches. Every monthly price includes your face-to-face consultation, blood pressure check, and weight check. There are no additional charges for clinical monitoring.
For patients with type 2 diabetes, the monthly price covers more than medication. It covers regular monitoring from a prescriber who knows your case and can discuss any changes in how you are feeling alongside the weight and blood pressure checks. For a full comparison of Mounjaro with Wegovy, see our Mounjaro vs Wegovy Swansea guide.
“The team at Medihub are very welcoming and friendly. Always extremely helpful.”
Catia M. — Google Review
Frequently Asked Questions
The difficulty with type 2 diabetes is that the condition and the weight are bound together in ways that make each one harder to address on its own. Losing weight improves blood sugar. Better blood sugar control supports metabolic health. But the standard treatment path often addresses one without adequately supporting the other. Mounjaro works on both mechanisms at once, which is why its results in people with type 2 diabetes are clinically distinct from those of older treatments.
Medihub does not replace your existing diabetes care. What it offers is a face-to-face consultation with a qualified prescriber who takes your full health picture seriously, a weight management programme that has a measurable secondary effect on blood sugar, and monthly clinical oversight from someone who has actually met you. Two branches in Swansea. No GP referral required. If you are eligible, you leave with a prescription the same day.
Book your Mounjaro consultation in Swansea
Killay and Pontarddulais. Face-to-face. Same-day prescribing. No GP referral needed.
Reviewed and verified by
Osama Al-Saied, Independent Prescriber
GPhC Number: 2222112 | Independent Prescriber
Medihub Pharmacy, Killay, Swansea
Pharmacy GPhC Registration: 9012258 — verify on the GPhC register
